Scholarly article on N-Benzolsulfonylaminoisomaleimid 30986-27-7 from Journal of the American Chemical Society p. 5873,5876

DOI: 10.1021/ja01554a074

Source and publish data:

Journal of the American Chemical Society p. 5873,5876 (1958)

Update date:2022-08-02

Topics:

Authors:

Feuer Feuer

Rubinstein

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01554a074

Full text of DOI:10.1021/ja01554a074

Products guided by the article

Product name:N-Benzolsulfonylaminoisomaleimid

Cas No:30986-27-7

R&D Labs maybe for 30986-27-7

SHUNYUANSHENG BIO-PHARMTECH CO., LTD

website:https://www.whsysbio.com

Contact:--

Address:Building 13, Liandong U Valley-Wuhan Economic Innovation Valley, No. 259, Xingsan Road, Shamao Street, Hannan District, Wuhan City, Hubei Province
Jewim Pharmaceutical (Shandong) Co., Ltd

Contact:+8615621883869

Address:山东省泰安市高新技术产业开发区配天门大街西首
Shandong LuZhou Amino Acid Co., Ltd

Contact:86-539-2218025

Address:yishui economic and technical development zone zhenxing south road
Cangzhou Senary Chemical Science-tech Co., Ltd

Contact:+86-317-3563899, 3563699

Address:168 Jinde Road, Cangzhou, Hebei, China
NINGBO YINZHOU PRECISE COLOR CO.,LTD.

Contact:86-574-88139809 86-574-83033159

Address:Qiming Road,Yinzhou,Ningbo,China

Relevant to this article

Pd-catalyzed hydrogenolysis of 4,5-epoxy-2-alkenoates: Model study of the acyl side-chain of polyoxypeptin

Doi:10.1016/S0040-4039(00)01281-8
(2000)
Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones

Doi:10.1016/j.bmcl.2017.05.030
(2017)
Regioselective sulfamoylation at low temperature enables concise syntheses of putative small molecule inhibitors of sulfatases

Doi:10.1039/c5ob00211g
(2015)
Solution- and solid-phase synthesis of peptide-substituted thiazolidinediones as potential PPAR ligands

Doi:10.1016/S0960-894X(00)00440-6
(2000)
Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders

Doi:10.1021/jm401958n
(2014)
Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3- dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain

Doi:10.1007/s12272-013-0062-1
(2013)

Article Doi

DOI: 10.1021/ja01554a074